NeuroMetrix, Inc. Announces Date for Second Quarter 2020 Financial Results Conference Call
July 16, 2020 15:14 ET
|
NeuroMetrix, Inc.
WOBURN, Mass., July 16, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2020 second quarter financial results before the opening of the market on...
NeuroMetrix Reports DPNCheck® Expansion in China
July 09, 2020 13:00 ET
|
NeuroMetrix, Inc.
WOBURN, Mass., July 09, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced expanded distribution in China for DPNCheck, a fast, accurate and quantitative nerve conduction test...
NeuroMetrix Signs DPNCheck® Collaboration Agreement with Biomedix
June 25, 2020 13:00 ET
|
NeuroMetrix, Inc.
WOBURN, Mass., June 25, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it has signed a collaboration agreement with Biomedix to comarket DPNCheck for peripheral...
NeuroMetrix to Target Chronic Knee Pain with Quell® 2.0 Wearable Pain Relief Device
June 10, 2020 13:00 ET
|
NeuroMetrix, Inc.
WOBURN, Mass., June 10, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it has launched a marketing initiative focusing on chronic knee pain. This effort includes...
NeuroMetrix Reports Q1 2020 Financial Results
April 23, 2020 07:00 ET
|
NeuroMetrix, Inc.
WOBURN, Mass., April 23, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2020. The Company is a leading...
NeuroMetrix Reports Quell® Technology to be Used in NIH-Funded Trial Evaluating Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS) for Fibromyalgia
April 16, 2020 13:30 ET
|
NeuroMetrix, Inc.
WOBURN, Mass., April 16, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that Quell technology has been selected for use in a large, NIH-funded, randomized, pragmatic...
NeuroMetrix, Inc. Announces Date for First Quarter 2020 Financial Results Conference Call
April 16, 2020 11:00 ET
|
NeuroMetrix, Inc.
WOBURN, Mass., April 16, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2020 first quarter financial results before the opening of the market on...
NeuroMetrix Announces 2020 Annual Meeting of Shareholders Will Be Held in Virtual Meeting Format Only
April 10, 2020 13:42 ET
|
NeuroMetrix, Inc.
WOBURN, Mass., April 10, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that, due to the public health impact of the COVID-19 pandemic and in accordance with orders issued...
NeuroMetrix Provides Quell® Technology Commercial Strategy and Pipeline Update
March 11, 2020 11:00 ET
|
NeuroMetrix, Inc.
WOBURN, Mass., March 11, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today provided an update on its Quell technology commercial strategy and pipeline. An estimated 100 million US...
NeuroMetrix Reports Clinical Studies Recently Published on DPNCheck®
March 05, 2020 12:14 ET
|
NeuroMetrix, Inc.
WOBURN, Mass., March 05, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported the recent publication of three additional DPNCheck clinical studies. DPNCheck is a point-of-care...